CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) |
12 Months Ended | |||
|---|---|---|---|---|
|
Dec. 31, 2025
CNY (¥)
¥ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
CNY (¥)
¥ / shares
shares
|
Dec. 31, 2023
CNY (¥)
¥ / shares
shares
|
|
| Net revenues (include related party revenues of RMB62,849,416, RMB48,935,143 and RMB51,847,377 for the years ended December 31, 2023, 2024 and 2025, respectively) | ¥ 3,818,851,679 | $ 546,088,526 | ¥ 4,270,825,456 | ¥ 5,530,404,557 |
| Cost of revenues (include related party cost of revenues of RMB667,324,933, RMB485,973,979 and RMB416,938,750 for the years ended December 31, 2023, 2024 and 2025, respectively) | (3,329,325,336) | (476,087,191) | (3,946,992,974) | (4,846,371,264) |
| Gross profit | 489,526,343 | 70,001,335 | 323,832,482 | 684,033,293 |
| Operating (expenses) income: | ||||
| Sales and marketing expenses | (234,482,022) | (33,530,483) | (311,140,438) | (351,726,623) |
| General and administrative expenses | (137,656,630) | (19,684,636) | (204,428,800) | (237,755,845) |
| Research and development expenses | (121,058,278) | (17,311,103) | (181,676,080) | (276,935,538) |
| Other operating income (expenses), net | 8,426,888 | 1,205,029 | (200,174,118) | 32,314,541 |
| Impairment of goodwill | ¥ | (13,966,789) | |||
| Total operating expenses | (484,770,042) | (69,321,193) | (897,419,436) | (848,070,254) |
| (Loss) income from operations | 4,756,301 | 680,142 | (573,586,954) | (164,036,961) |
| Other (expenses) income, net | (67,314,858) | (9,625,897) | 21,898,241 | (52,873,716) |
| Interest income | 64,330,349 | 9,199,118 | 263,052,300 | 284,982,128 |
| Foreign exchange gain (loss), net | (517,288) | (73,971) | 1,233,807 | 125,893 |
| Income (loss) before income taxes and share of loss in equity method investments | 1,254,504 | 179,392 | (287,402,606) | 68,197,344 |
| Income tax expense | (28,408,570) | (4,062,372) | (15,406,551) | (1,068,958) |
| Share of loss in equity method investments | (1,927,859) | (275,680) | (4,001,129) | (31,610,752) |
| Net income (loss) | (29,081,925) | (4,158,660) | (306,810,286) | 35,517,634 |
| Net income (loss) attributable to ordinary shareholders of the Company | ¥ (29,081,925) | $ (4,158,660) | ¥ (306,810,286) | ¥ 35,517,634 |
| Net income (loss) per ordinary share attributable to ordinary shareholders | ||||
| Basic (in dollars per share) | (per share) | ¥ (0.96) | $ (0.14) | ¥ (9.95) | ¥ 1.11 |
| Diluted (in dollars per share) | (per share) | ¥ (0.96) | $ (0.14) | ¥ (9.95) | ¥ 1.11 |
| Weighted average shares used in calculating net income (loss) per ordinary share | ||||
| Basic (in shares) | 30,178,859 | 30,178,859 | 30,832,271 | 31,977,665 |
| Diluted (in shares) | 30,178,859 | 30,178,859 | 30,832,271 | 31,977,665 |
| Net income (loss) | ¥ (29,081,925) | $ (4,158,660) | ¥ (306,810,286) | ¥ 35,517,634 |
| Other comprehensive income (loss), net of nil tax: | ||||
| Foreign currency translation adjustments | (42,854,121) | (6,128,058) | 72,141,058 | 93,256,170 |
| Comprehensive income (loss) | (71,936,046) | (10,286,718) | (234,669,228) | 128,773,804 |
| Comprehensive income (loss) attributable to the ordinary shareholders | ¥ (71,936,046) | $ (10,286,718) | ¥ (234,669,228) | ¥ 128,773,804 |
| ADS | ||||
| Net income (loss) per ordinary share attributable to ordinary shareholders | ||||
| Basic (in dollars per share) | (per share) | ¥ (0.96) | $ (0.14) | ¥ (9.95) | ¥ 1.11 |
| Diluted (in dollars per share) | (per share) | ¥ (0.96) | $ (0.14) | ¥ (9.95) | ¥ 1.11 |
| Weighted average shares used in calculating net income (loss) per ordinary share | ||||
| Basic (in shares) | 30,178,859 | 30,178,859 | 30,832,271 | 31,977,665 |
| Diluted (in shares) | 30,178,859 | 30,178,859 | 30,832,271 | 31,977,665 |
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Interest income derived from funds deposited with both domestic and foreign financial institutions including funds in money market and other accounts. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. No definition available.
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|